Cancer Immunotherapy Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
XLO | C | Xilio Therapeutics, Inc. | -1.87 | |
HOWL | C | Werewolf Therapeutics, Inc. | -5.43 | |
CNCR | D | Loncar Cancer Immunotherapy ETF | 0.14 | |
TIL | D | Instil Bio, Inc. | -1.82 | |
IOVA | D | Iovance Biotherapeutics, Inc. | -2.44 | |
ZYME | D | Zymeworks Inc. | 0.11 | |
NBTX | D | Nanobiotix S.A. | -0.15 | |
EVAX | D | Evaxion Biotech A/S | 4.12 | |
GNTA | D | Genenta Science S.p.A. | 0.00 | |
IMNM | D | Immunome, Inc. | -0.84 |
Related Industries: Biotechnology Other
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
CNCR | D | Loncar Cancer Immunotherapy ETF | 2.26 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 1.64 | |
IDNA | C | iShares Genomics Immunology and Healthcare ETF | 1.01 | |
FORH | C | Formidable ETF | 1.0 | |
SBIO | D | ALPS Medical Breakthroughs ETF | 1.0 |
Compare ETFs
- Cancer Immunotherapy
Cancer immunotherapy (sometimes called immuno-oncology) is the artificial stimulation of the immune system to treat cancer, improving on the system's natural ability to fight cancer. It is an application of the fundamental research of cancer immunology and a growing subspecialty of oncology. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules (e.g. carbohydrates). Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill.
Popular Now
Recent Comments
- TraderMike on Market Recap for Tuesday, May 21, 2024
- CharmingMole371 on Market Recap for Tuesday, May 21, 2024
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
From the Blog
Featured Articles